Who benefits most from CGM on GLP-1 medications?
Whether CGM is useful depends on the condition, treatment and intended use. No trial reviewed here establishes a universal CGM winner for GLP-1 users.
Type 2 diabetes patients on Ozempic. If you're taking semaglutide for blood sugar management, CGM gives you daily data between laboratory HbA1c checks. You can track whether your glucose targets are being met, catch unexpected spikes, and bring richer data to your next appointment.
CGM can supply glucose observations for discussion with your prescriber, but a personal trace does not establish medication efficacy, dose adequacy or the cause of a change. Do not adjust or switch medication from sensor data; follow the prescribed plan.
CGM can supply glucose observations for discussion with your prescriber, but a personal trace does not establish medication efficacy, dose adequacy or the cause of a change. Do not adjust or switch medication from sensor data; follow the prescribed plan.
CGM shows interstitial glucose alongside logged events. Associations in one person’s trace do not prove a meal, activity, sleep or stress caused the change. Glucose alone does not measure insulin, fat burning, energy availability or overall metabolic health.
Best CGM devices for GLP-1 users in 2026
Dexcom Stelo is one OTC option with model-specific limits, including no clinical high/low alarms. Semaglutide labeling warns of increased hypoglycemia risk with insulin or sulfonylureas. Not using insulin alone does not establish that an OTC device without clinical low-glucose alarms is suitable. Discuss medication risks and device selection with your prescriber. Read our review →
Nutrisense currently lists Dexcom Stelo among its products. Coaching plans provide access to registered dietitians. Check the selected plan for sensor quantity, coaching and service eligibility; the device’s FDA indication does not determine eligibility for the service. Coaching does not measure medication efficacy. Read our review →
OTC option: Abbott Lingo
The app presents a glucose graph and a proprietary Lingo Count based on identified spikes. These features do not establish that it is easier for a new user. Full review →
For insulin users: FreeStyle Libre 3 (prescription)
If you use insulin alongside your GLP-1, you need a prescription CGM. The Libre 3 is one prescription option; ask your prescriber which CGM fits, and check coverage with your insurer. Full review →
CGM options for GLP-1 users compared
| Device | Price/month | Prescription? | Cleared for / notes |
|---|---|---|---|
| Dexcom Stelo | Check price | No | Check suitability with prescriber |
| Nutrisense | Check price | No | Dietitian coaching; Stelo sensor |
| Abbott Lingo | Check price | No | Adults 18+ not on insulin; over the counter |
| FreeStyle Libre 3 | Check exact plan | Yes | People with diabetes: ages 4+ (Libre 3), ages 2+ (Libre 3 Plus) |
| Dexcom G7 | Check exact plan | Yes | People with diabetes, ages 2+ |
Do you need a prescription on GLP-1 medications?
Semaglutide labeling warns of increased hypoglycemia risk with insulin or sulfonylureas. Not using insulin alone does not establish that an OTC device without clinical low-glucose alarms is suitable. Discuss medication risks and device selection with your prescriber. Dexcom Stelo is an over-the-counter device for people aged 2 years and older who do not use insulin, with caregiver supervision below 18. It is not intended for problematic hypoglycemia or dialysis and has no clinical high/low alarms. Platform enrollment may have narrower eligibility.
If using insulin, choose an appropriately cleared prescription CGM with your prescriber. Insurance depends on all plan criteria.
Never use an OTC CGM to make insulin dosing decisions. In the US, Stelo and Lingo are FDA-cleared for adults aged 18 and older (Lingo) or people aged 2 years and older (Stelo, since June 2026) who do not use insulin and are not intended for insulin dosing; talk to a healthcare professional before acting on readings.